Wire · opportunities
Medtronic launches Aristotle Mini Guidewire for chronic subdural hematoma
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 15 November 2026 · Fusion42 review
Medtronic has launched the Aristotle Mini Guidewire after FDA clearance, expanding its portfolio for treating chronic subdural hematoma by enabling better access to small, distal vessels in neurovascular procedures. This device complements existing Medtronic neurovascular technologies and aims to improve treatment precision and physician confidence.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 9 Nov 2026 and 15 Nov 2026.
◆ ◆ The Wire takeaway
You now have a lower-profile tool to access complex neurovascular anatomy with more confidence and flexibility. Medtronic's advancement means you can improve procedural precision for chronic subdural hematoma and related conditions starting this quarter.
◆ Coverage
3 sources · first reported 9 Nov 2026 · latest 15 Nov 2026
◆ Related on Wire
◆ Topics